Cellectar Biosciences, Inc. — Director's Dealing 2018

Dec 1, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cellectar Biosciences, Inc. (CLRB)
CIK: 0001279704
Period of Report: 2018-11-29

Reporting Person: HILL STEPHEN A (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-11-29	Common Stock	S	939	$2.2101	Disposed	53	Direct
2018-11-29	Common Stock	S	53	$2.21	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-11-29	Series A Warrants	$30.40	S	9390	Acquired	2021-04-20	Common Stock (9390)	Direct
2018-11-29	Warrants	$468.00	S	530	Acquired	2019-08-20	Common Stock (530)	Direct